Diminished Neural Processing of Aversive and Rewarding Stimuli During Selective Serotonin Reuptake Inhibitor Treatment

Biological Psychiatry

Volumn 67, Issue 5, 2010, Pages 439-445

  McCabe, Ciara ^a   Mishor, Zevic ^a   Cowen, Philip J ^a   Harmer, Catherine J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antidepressants; depression; fMRI; reward; SSRI; ventral striatum

Indexed keywords

CITALOPRAM; PLACEBO; REBOXETINE;

ADULT; ANHEDONIA; ARTICLE; AVERSION; BECK DEPRESSION INVENTORY; BODY MASS; BRAIN FUNCTION; CACAO; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DRUG EFFECT; EATING ATTITUDES TEST QUESTIONNAIRE; FAWCETT CLARKE PLEASURE SCALE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; MALE; NEUROBIOLOGY; NEUROIMAGING; NORMAL HUMAN; ORBITAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REWARD; SNAITH HAMILTON PLEASURE SCALE; STIMULUS RESPONSE; STRAWBERRY;

ADRENERGIC UPTAKE INHIBITORS; ADULT; AFFECT; ANXIETY DISORDERS; CITALOPRAM; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MORPHOLINES; NERVE NET; REWARD; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 75949117878     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.11.001     Document Type: Article

References (51)

1. Bauer M., Monz B.U., Montejo A.L., Quail D., Dantchev N., Demyttenaere K., et al. Prescribing patterns of antidepressants in Europe: Results from the factors influencing depression endpoints research (FINDER) study. Eur Psychiatry 23 (2008) 66-73
2. Fergusson D., Doucette S., Glass K.C., Shapiro S., Healy D., Hebert P., et al. Association between suicide attempts and selective serotonin reuptake inhibitors: Systematic review of randomised controlled trials. BMJ 330 (2005) 396
3. Turner E.H., Matthews A.M., Linardatos E., Tell R.A., and Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 358 (2008) 252-260
4. Watson D., O'Hara M.W., and Stuart S. Hierarchical structures of affect and psychopathology and their implications for the classification of emotional disorders. Depress Anxiety 25 (2008) 282-288
5. Shelton R.C., and Tomarken A.J. Can recovery from depression be achieved?. Psychiatr Serv 52 (2001) 1469-1478
6. Opbroek A., Delgado P.L., Laukes C., McGahuey C., Katsanis J., Moreno F.A., et al. Emotional blunting associated with SSRI-induced sexual dysfunction. Do SSRIs inhibit emotional responses?. Int J Neuropsychopharmacol 5 (2002) 147-151
7. Price J., Cole V., and Goodwin G.M. Emotional side-effects of selective serotonin reuptake inhibitors: Qualitative study. Br J Psychiatry 195 (2009) 211-217
8. Zald D.H., and Depue R.A. Serotonergic functioning correlates with positive and negaitive affect in psychiatrically healthy males. Personal Individ Differences 30 (2001) 71-86
9. Hasler G., Drevets W.C., Manji H.K., and Charney D.S. Discovering endophenotypes for major depression. Neuropsychopharmacology 29 (2004) 1765-1781
10. Nutt D., Demyttenaere K., Janka Z., Aarre T., Bourin M., Canonico P.L., et al. The other face of depression, reduced positive affect: The role of catecholamines in causation and cure. J Psychopharmacol 21 (2007) 461-471
11. Dekeyne A., Gobert A., Auclair A., Girardon S., and Millan M.J. Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors. Psychopharmacology 162 (2002) 156-167
12. Fitzgerald D.A., Posse S., Moore G.J., Tancer M.E., Nathan P.J., and Phan K.L. Neural correlates of internally-generated disgust via autobiographical recall: A functional magnetic resonance imaging investigation. Neurosci Lett 370 (2004) 91-96
13. McCabe C., Cowen P.J., and Harmer C.J. Neural representation of reward in recovered depressed patients. Psychopharmacology (2009)
14. Spitzer R.L., Williams J.B., Gibbon M., and First M.B. Structured clinical interview for the DSM-IV (SCID-I/P) (2004)
15. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 4 (1961) 561-571
16. Spielberger C.D. Manual for the State-Trait Anxiety Inventory (1983), Consulting Psychologists Publishing, Palo Alto, CA
17. Fawcett J., Clark D.C., Scheftner W.A., and Gibbons R.D. Assessing anhedonia in psychiatric patients. Arch Gen Psychiatry 40 (1983) 79-84
18. Snaith R.P., Hamilton M., Morley S., Humayan A., Hargreaves D., and Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry 167 (1995) 99-103
19. Rolls E.T., and McCabe C. Enhanced affective brain representations of chocolate in cravers vs. non-cravers. Eur J Neurosci 26 (2007) 1067-1076
20. Garner D.M., Olmsted M.P., Bohr Y., and Garfinkel P.E. The eating attitudes test: Psychometric features and clinical correlates. Psychol Med 12 (1982) 871-878
21. O'Doherty J., Rolls E.T., Francis S., Bowtell R., and McGlone F. The representation of pleasant and aversive taste in the human brain. J Neurophysiol 85 (2001) 1315-1321
22. de Araujo I.E.T., Kringelbach M.L., Rolls E.T., and Hobden P. The representation of umami taste in the human brain. J Neurophysiol 90 (2003) 313-319
23. de Araujo I.E.T., Kringelbach M.L., Rolls E.T., and McGlone F. Human cortical responses to water in the mouth, and the effects of thirst. J Neurophysiol 90 (2003) 1865-1876
24. de Araujo I.E.T., and Rolls E.T. The representation in the human brain of food texture and oral fat. J Neurosci 24 (2004) 3086-3093
25. Wilson J.L., Jenkinson M., de Araujo I., Kringelbach M.L., Rolls E.T., and Jezzard P. Fast, fully automated global and local magnetic field optimization for fMRI of the human brain. Neuroimage 17 (2002) 967-976
26. Collins D.L., Neelin P., Peters T.M., and Evans A.C. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J Comput Assist Tomogr 18 (1994) 192-205
27. Friston K.J., Glaser D.E., Henson R.N., Kiebel S., Phillips C., and Ashburner J. Classical and Bayesian inference in neuroimaging: Applications. Neuroimage 16 (2002) 484-512
28. Friston K.J., Worsley K.J., Frackowiak R.S.J., Mazziotta J.C., and Evans A.C. Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp 1 (1994) 214-220
29. Worsley K.J., Marrett P., Neelin A.C., Friston K.J., and Evans A.C. A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 4 (1996) 58 73
30. Glascher J., and Gitelman D. Contrast weights in flexible factorial design with multiple groups of subjects (2008). https://www.jiscmail.ac.uk/cgi-bin/webadmin?A2=ind0803&L=SPM&P=R 16629
31. McCabe C., Rolls E.T., Bilderbeck A., and McGlone F. Cognitive influences on the affective representation of touch and the sight of touch in the human brain. Soc Cogn Affect Neurosci 3 (2008) 97-108
32. Maldjian J.A., Laurienti P.J., Kraft R.A., and Burdette J.H. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI datasets. Neuroimage 19 (2003) 1233-1239
33. Epstein J., Pan H., Kocsis J.H., Yang Y., Butler T., Chusid J., et al. Lack of ventral striatal response to positive stimuli in depressed versus normal subjects. Am J Psychiatry 163 (2006) 1784-1790
34. Knutson B., Bhanji J.P., Cooney R.E., Atlas L.Y., and Gotlib I.H. Neural responses to monetary incentives in major depression. Biol Psychiatry 63 (2008) 686-692
35. Baldwin D.S., Anderson I.M., Nutt D.J., Bandelow B., Bond A., Davidson J.R., et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: Recommendations from the British Association for Psychopharmacology. J Psychopharmacol 19 (2005) 567-596
36. Oleshansky M.A., and Labbate L.A. Inability to cry during SRI treatment. J Clin Psychiatry 57 (1996) 593
37. Taylor M.J., Freemantle N., Geddes J.R., and Bhagwagar Z. Early onset of selective serotonin reuptake inhibitor antidepressant action: Systematic review and meta-analysis. Arch Gen Psychiatry 63 (2006) 1217-1223
38. Harmer C.J., Shelley N.C., Cowen P.J., and Goodwin G.M. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry 161 (2004) 1256-1263
39. Dannon P.N., Iancu I., Lowengrub K., Gonopolsky Y., Musin E., Grunhaus L., et al. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder. Clin Neuropharmacol 30 (2007) 326-334
40. Halford J.C., Harrold J.A., Boyland E.J., Lawton C.L., and Blundell J.E. Serotonergic drugs: Effects on appetite expression and use for the treatment of obesity. Drugs 67 (2007) 27-55
41. Stice E., Spoor S., Bohon C., and Small D.M. Relation between obesity and blunted striatal response to food is moderated by Taq1A A1 allele. Science 322 (2008) 449-452
42. Arroll B., Elley C.R., Fishman T., Goodyear-Smith F.A., Kenealy T., Blashki G., et al. Antidepressants versus placebo for depression in primary care. Cochrane Database Syst Rev (2009) CD:007954
43. Ipser J.C., Stein D.J., Hawkridge S., and Hoppe L. Pharmacotherapy for anxiety disorders in children and adolescents. Cochrane Database Syst. Rev (2009) CD:005170
44. Nelson J.C., Portera L., and Leon A.C. Are there differences in the symptoms that respond to a selective serotonin or norepinephrine reuptake inhibitor?. Biol Psychiatry 57 (2005) 1535-1542
45. Trivedi M.H., Hollander E., Nutt D., and Blier P. Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression. J Clin Psychiatry 69 (2008) 246-258
46. Papakostas G.I., Nutt D.J., Hallett L.A., Tucker V.L., Krishen A., and Fava M. Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors. Biol Psychiatry 60 (2006) 1350-1355
47. Papakostas G.I., Stahl S.M., Krishen A., Seifert C.A., Tucker V.L., Goodale E.P., et al. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): A pooled analysis of 10 studies. J Clin Psychiatry 69 (2008) 1287-1292
48. Papakostas G.I., Thase M.E., Fava M., Nelson J.C., and Shelton R.C. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder?. A meta-analysis of studies of newer agents. Biol Psychiatry 62 (2007) 1217-1227
49. Zisook S., Rush A.J., Haight B.R., Clines D.C., and Rockett C.B. Use of bupropion in combination with serotonin reuptake inhibitors. Biol Psychiatry 59 (2006) 203-210
50. Rush A.J., Trivedi M.H., Wisniewski S.R., Stewart J.W., Nierenberg A.A., Thase M.E., et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 354 (2006) 1231-1242
51. Trivedi M.H., Fava M., Wisniewski S.R., Thase M.E., Quitkin F., Warden D., et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med 354 (2006) 1243-1252